Who's it for?
Companies with a reasonable business model built on innovative drug candidates or technologies supported by a strong intellectual property position.
What problem does it solve?
It can be challenging to find long-term investors who can assist with product development and corporate development.
How does it help?
We regularly provide essential market, regulatory and drug development insights, as well as financial, operational and strategic advice, to portfolio company management through regular and uncompensated communications
We invest in opportunities at all stages of development and across multiple therapeutic areas in both private and public companies. Our goal at Cato BioVentures is to partner with our portfolio companies to make a difference in the successful outcome of your core development programs.